18F-NaF

DRUG4 trials

Sponsors

Cedars-Sinai Medical Center, National Cancer Institute (NCI), Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Akiva Mintz

Conditions

Aortic StenosisArthritisBone AlterationBone and Joint CancerBone and Joint InfectionHealthy VolunteerMetastatic Prostate CancerProstate Cancer

Phase 1

Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.

CompletedNCT03497377

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsMetastatic Prostate Cancer

Start: 2016-05-16End: 2020-04-30Updated: 2020-05-07

Phase 2

18-F Sodium Fluoride (18F-NaF) PET for the Assessment of Bioprosthetic Aortic Valve Durability and Outcomes

CompletedNCT03095313

Cedars-Sinai Medical CenterAortic Stenosis

Start: 2017-07-23End: 2024-02-16Updated: 2025-02-12

18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer

Active, not recruitingNCT03173924

National Cancer Institute (NCI)Metastatic Prostate Cancer, Prostate Cancer, Prostate Neoplasms +2

Start: 2017-06-06End: 2028-02-06Updated: 2026-09-03

Ultralow Dose PET Imaging for 18F-NaF Uptake

RecruitingNCT07284563

Akiva MintzArthritis, Bone Alteration, Bone and Joint Cancer +2

Start: 2025-09-01End: 2030-06-30Target: 200Updated: 2025-12-16